These findings demonstrate that circVPS35L has great potential as a novel biomarker for the diagnosis of NSCLC, and can be used to distinguish NSCLC from benign lung disease.
Peripheral Blood-derived CircVPS35L as a Potential Diagnostic Biomarker for Non-small Cell Lung Cancer.